Daniel A Hussar, Dean R Wetty. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Adrenergic beta-1 Receptor Agonists/adverse effectsAdrenergic beta-1 Receptor Agonists/therapeutic useBenzoxazines/adverse effectsBenzoxazines/therapeutic useBronchodilator Agents/adverse effectsBronchodilator Agents/therapeutic useGlucagon-Like Peptides/adverse effectsGlucagon-Like Peptides/analogs & derivativesGlucagon-Like Peptides/therapeutic useHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useImmunoglobulin Fc Fragments/adverse effectsImmunoglobulin Fc Fragments/therapeutic useLactones/adverse effectsLactones/therapeutic usePlatelet Aggregation Inhibitors/adverse effectsPlatelet Aggregation Inhibitors/therapeutic usePyridines/adverse effectsPyridines/therapeutic useRecombinant Fusion Proteins/adverse effectsRecombinant Fusion Proteins/therapeutic use
Substances： See more » Adrenergic beta-1 Receptor AgonistsBenzoxazinesBronchodilator AgentsHypoglycemic AgentsImmunoglobulin Fc FragmentsLactonesPlatelet Aggregation InhibitorsPyridinesRecombinant Fusion ProteinsGlucagon-Like Peptidesolodateroldulaglutidevorapaxar
Year: 2015 PMID： 25575154 DOI： 10.1331/JAPhA.2015.15504
Source DB: PubMed Journal: J Am Pharm Assoc (2003) ISSN： 1086-5802